As of Dec 02
| -0.0004 / -0.04%|
The 3 analysts offering 12-month price forecasts for Opexa Therapeutics Inc have a median target of 1.00, with a high estimate of 18.00 and a low estimate of 1.00. The median estimate represents a +8.71% increase from the last price of 0.92.
The current consensus among 4 polled investment analysts is to Hold stock in Opexa Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.